Archive | From your Diabetes Experts Subscribe

At the Heart of Diabetes Management

Issue 3 – At the Heart of Diabetes Management (PDF), download here Issue 3 – At the Heart of Diabetes Management Gearing up for New Ways of Potentially Reducing Cardiovascular Risk INTRO Cardiovascular disease (CVD) is the leading cause of mortality and morbidity for people living with diabetesi. In a series of presentations at LMC […]

Continue Reading →

Novel Therapies for Type 2 Diabetes on the Horizon: SGLT2 Inhibitors

Issue 2 – LDL-C and CRP in Clinical Practice: A 2005 Update (PDF), download here Issue 2 – LDL-C and CRP in Clinical Practice: A 2005 Update Ronald M. GoldenbergMD, FRCPC, FACE Targeting the Kidney for Type 2 Diabetes Management: SGLT2 Inh ibiti on The traditional management of type 2 diabetes focuses on agents with […]

Continue Reading →

DPP – 4 INHIBITORS Addressing Unmet Needs in Type 2 Diabetes

Issue 1 – DPP – 4 INHIBITORS Addressing Unmet Needs in Type 2 Diabetes (PDF), download here Issue 1 – DPP – 4 INHIBITORS Addressing Unmet Needs in Type 2 Diabetes Ronald M. GoldenbergMD, FRCPC, FACE The natural history of type 2 diabetes is one of progressively worsening hyperglycemia. The use of monotherapy with traditional […]

Continue Reading →

IFG vs. IGT: Shall We Treat?

IMPAIRED FASTING GLUCOSE (IFG) vs. IMPAIRED GLUCOSE TOLERANCE (IGT) Shall We Treat? Dr. Harpreet Bajaj MD, MPH, ECNU The Problem The Type 2 diabetes mellitus (T2DM) epidemic is growing rapidly, with an estimated 285 million people worldwide living with T2DM in 2010. Almost half of those affected are in the 20-60 age-group. It has been […]

Continue Reading →

CV Risk Management in CKD: What Works?

Murray Berall, MD Nephrologist, HRRH Lecturer, University of Toronto The management of cholesterol in patients with chronic kidney disease (CKD) has been controversial. Until recently, this debate has been fueled by a lack of supportive studies. Patients reaching dialysis have a high mortality from cardiac causes. Most of these events are not due to atherosclerosis. […]

Continue Reading →

Clinical Controversies in Diabetes – Toronto 2011

Issue 4 – Clinical Controversies in Diabetes – Toronto 2011 (PDF), download here Issue 4 – Clinical Controversies in Diabetes – Toronto 2011 MODERATOR Alice Cheng MB, FRCPC Staff Endocrinologist, St. Michael’s Hospital & Credit Valley Hospital Assistant Professor of Medicine University of Toronto Chair, CDA Clinical Practice Guidelines Committee CONTROVERSIES FROM THE ENDOCRINOLOGIST Stuart […]

Continue Reading →

Impaired Fasting Glucose (IFG) or Impaired Glucose Tolerance (IGT)

Issue 3 – Impaired Fasting Glucose (IFG) or Impaired Glucose Tolerance (IGT) (PDF), download here Issue 3 – Impaired Fasting Glucose (IFG) or Impaired Glucose Tolerance (IGT) IMPAIRED FASTING GLUCOSE (IFG) vs. IMPAIRED GLUCOSE TOLERANCE (IGT) Shall We Treat? Dr. Harpreet Bajaj MD, MPH, ECNU The Problem The Type 2 diabetes mellitus (T2DM) epidemic is […]

Continue Reading →

CV Risk Management in CKD: What works?

Issue 2 – LDL-C and CRP in Clinical Practice: A 2005 Update (PDF), download here Issue 2 – LDL-C and CRP in Clinical Practice: A 2005 Update Dr. Murray Berall,NEPHROLOGIST, HRRHLECTURER,UNIVERSITY OF TORONTO The management of cholesterol in patients with chronic kidney disease (CKD) has been controversial. Until recently, this debate has been fueled by […]

Continue Reading →

Dyslipidemia

Issue 1 – Dyslipidemia (PDF), download here Issue 1 – Dyslipidemia Robert Schlosser,MD, FRCPC The 2009 Canadian guidelines for the diagnosis and treatment of dyslipidemia and the prevention of cardiovascular disease in the adult were published in the October 2009 issue of the Canadian Journal of Cardiology1. They provide the latest evidence-based recommendations and standards […]

Continue Reading →

Dyslipidemia

Robert Schlosser, MD, FRCPC The 2009 Canadian guidelines for the diagnosis and treatment of dyslipidemia and the prevention of cardiovascular disease in the adult were published in the October 2009 issue of the Canadian Journal of Cardiology (1). They provide the latest evidence-based recommendations and standards for identifying patients at risk, lipid modification and CVD […]

Continue Reading →

Articles and resources posted on this website are for general information purposes only. They are not meant to provide medical advice for any medical condition and/or replace care by healthcare professionals. Please contact your healthcare provider regarding your medical condition.

Copyright © 2013 LMC Diabetessource | Site Design, SEO & Maintenance: Net Squares Inc. | Terms & Conditions